MMP14 and cancer: We had previously identified and validated HSP90 as one antigen for patient autoantibodies through a stringent biochemical approach; this does not, however, rule out the possibility that HSP90 and MMP14, among other MMPs, may all represent accessible anti‐cancer drug targets.